Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookNational Guidelines for the Clinical Management of HIV/AIDS - Tanzania (NACP; 2005; 131 pages)
View the documentLIST OF ABBREVIATIONS
View the documentACKNOWLEDGEMENTS
View the documentFOREWORD
Open this folder and view contentsCHAPTER 1: INTRODUCTION
close this folderCHAPTER 2: ORGANIZATION OF HIV/AIDS CARE AND TREATMENT
View the document2.1 Overview
View the document2.2 Serostatus Determination
View the document2.3 Scope of Care and Treatment
close this folder2.4 Care and Treatment for those on Antiretroviral Therapy (ART)
View the document2.4.1 Patient Visits Plan
View the document2.4.2 Adherence management and lifestyle counselling
View the document2.4.3 Medical Records System
Open this folder and view contents2.5 Linkages
Open this folder and view contentsCHAPTER 3: HIV/AIDS PREVENTION
Open this folder and view contentsCHAPTER 4: PROTECTIVE MEASURES AGAINST HIV TRANSMISSION
Open this folder and view contentsCHAPTER 5: LABORATORY TESTS IN HIV/AIDS
Open this folder and view contentsCHAPTER 6: HIV/AIDS AND PREGNANCY
Open this folder and view contentsCHAPTER 7: PEDIATRIC HIV/AIDS AND RELATED CONDITIONS
Open this folder and view contentsCHAPTER 8: COMMUNITY AND HOME BASED CARE FOR PEOPLE LIVING WITH HIV/AIDS (PLHA)
Open this folder and view contentsCHAPTER 9: COUNSELLING RELATED TO HIV-TESTING AND TREATMENT ADHERENCE
Open this folder and view contentsCHAPTER 10: MANAGEMENT OF COMMON SYMPTOMS AND OPPORTUNISTIC INFECTIONS IN HIV/AIDS
Open this folder and view contentsCHAPTER 11: MANAGEMENT OF MENTAL HEALTH PROBLEMS IN HIV/AIDS
Open this folder and view contentsCHAPTER 12: MANAGEMENT OF HIV INFECTED PATIENTS USING ANTIRETROVIRAL DRUGS
Open this folder and view contentsCHAPTER 13: ARV THERAPY IN INFANTS AND CHILDREN
Open this folder and view contentsCHAPTER 14: USE OF ARVS IN SPECIAL CIRCUMSTANCES
Open this folder and view contentsCHAPTER 15: HIV/AIDS AND NUTRITION
Open this folder and view contentsCHAPTER 16: MANAGEMENT OF ANTIRETROVIRAL MEDICINES
Open this folder and view contentsCHAPTER 17: CERTIFICATION OF HEALTHCARE FACILITIES AS CARE AND TREATMENT SITES
 

2.4.1 Patient Visits Plan

Once a patient is identified, he or she will be referred to the CTC. At the initial clinic visit a triage nurse will assess patients needs, register basic information, issue relevant forms, weigh and direct patient to relevant sites. Blood will be drawn for a confirmatory HIV test if there is doubt on their status, and CD4 cell count, before the patient meets with a counsellor. Given that test results will typically not be available on the same day, the patient will be scheduled for a follow-up visit with a clinician to discuss the test results.

At the follow-up visit, after consultation with a clinician, patients who are recommended for and agree to initiate therapy will meet with a counsellor to discuss about adherence, medication dosing and adverse event management. They will have another blood sample drawn for tests which will help inform the treatment protocol and to identify baseline values for monitoring toxicity. Patients will be scheduled for follow-up after two weeks, then monthly for the first six months for clinical care and monitoring of response to therapy (including toxicity management). During these visits, they will see an evaluating clinician, pick up their medication from the pharmacy, and meet with a counsellor (see counselling section below). After six months, the patient will be requested to visit the clinic once a month for medication and counselling and as needed for clinical care. At six months intervals, CD4 counts and basic blood tests will be performed and patients will see an evaluating clinician for follow-up and to evaluate response to therapy.

For those who do not immediately qualify for treatment, regular monitoring of their status will be required as follows:

Asymptomatic (WHO stage I): Periodic monitoring will be required, with CD4 cell counts, and staging visits being done every 6 months

Symptomatic (WHO stage II, and stage III who do not qualify): Regular monitoring will be necessary, with CD4 counts and staging being done every (4 months).

All patients are however to be advised to come into the CTC immediately should their condition deteriorate prior to their next scheduled visit.

to previous sectionto next section

Please provide your feedback English  |  French